Biotech

Latest Articles

Cassava pays for $40M over allegedly misleading Alzheimer's upgrade

.Cassava Sciences has actually consented to pay $40 million to fix an inspection in to insurance cla...

Merck bags possibilities on Evaxion's AI-designed vaccine applicants

.Merck &amp Co. has gotten choices on 2 Evaxion Biotech injection candidates, paying for $3.2 millio...

Enanta's RSV antiviral crushes popular bunch in challenge research

.Enanta Pharmaceuticals has actually connected its own respiratory syncytial virus (RSV) antiviral t...

Biogen containers SAGE-324 partnership after crucial agitation fall short

.Biogen has provided the last rites to its own cooperation along with Sage Rehabs on SAGE-324, break...

AbbVie Parkinson's drug from $8.7 B Cerevel acquistion scores

.On the same day that some Parkinson's condition medicines are actually being actually called into q...

Arch finalizes $3B-plus fund to nurture biopharma startups

.On the heels of a $3 billion fund from Bain Capital Life Sciences, Arc Endeavor Allies is actually ...

Orion to make use of Aitia's 'digital twins' to locate brand new cancer cells medicines

.Finnish biotech Orion has actually snooped potential in Aitia's "electronic twin" technology to dev...

Windtree's surprise med rears high blood pressure in latest phase 2 win

.While Windtree Therapies has had a hard time to increase the economic roots needed to survive, a ph...

2 cancer biotechs combine, creating global impact

.OncoC4 is actually taking AcroImmune-- as well as its internal clinical production abilities-- unde...

Amgen reports very first period 3 gain for $400M dermatitis medication

.Amgen has actually discussed (PDF) the very first stage 3 records on its $400 million eczema drug, ...

Biogen, UCB document phase 3 lupus gain after failing earlier trial

.Biogen as well as UCB's bet one's bottom dollar developing right into stage 3 astride an unsuccessf...

Aptadir hopes new RNA inhibitors may turn around complicated cancers cells

.Italian biotech Aptadir Therapies has launched with the guarantee that its own pipeline of preclini...

Wave surfs DMD results to regulatory authorities' doors, sending out stock up

.Surge Life Sciences has actually fulfilled its own goal in a Duchenne muscular dystrophy (DMD) rese...

Sanofi plucks brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, occupying the...

Achilles drips cell therapy plan, bandages for unemployments after missing out on 'business viability' targets

.Achilles Therapeutics has actually torn up its technique. The British biotech is knocking off on it...

Aligos declares stage 2 MASH win, lowering liver body fat approximately 46%

.Aligos Therapies is actually proclaiming a midstage gain in metabolic-dysfunction affiliated steato...

Basilea credit ratings $268M BARDA backing for antifungals, anti-biotics

.Basilea Pharmaceutica's job developing brand new antifungals has obtained a significant boost comin...

Capricor sells Europe rights to late-stage DMD therapy for $35M

.Having actually scooped up the USA legal rights to Capricor Therapeutics' late-stage Duchenne muscl...

FDA junks adcomm for Applied's unusual illness medicine

.After dismissing the decision meeting for Applied Therapies' metabolic ailment drug govorestat, the...

Novo inks $600M NanoVation package to analyze genetic medications ex-liver

.Novo Nordisk is proceeding its own press into genetic medicines, accepting to compensate NanoVation...